StudyManager Expands into China
StudyManager (Seattle, WA), a developer of CTMS and EDC solutions, reports they recently expanded operations into China. The company's two newest customers are the Chinese CROs TigerMed and DMS-Pharma.
“China is the next logical step for us,” said Bruce Schatzman, Founder and Chief Executive Officer of StudyManager. “Because the cost of paper trials in China is still very competitive, we believe our EDC solution is a great choice when Chinese CROs and sponsors don’t see the price/performance value offered by larger EDC providers.”
To accomadate Asian expansion, StudyManager opened a data center in Shanghai, from which Chinese companies can run its EDC/CTMS system in what it calls "a secure and compliant manner."
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
